New CEO of Dexcom, Jake Leach, joined MobiHealthNews at the JPM Healthcare Conference to discuss his leadership priorities, CGM access and the role of wearables in preventive care.
Woori IO plans to accelerate its noninvasive CGM launch after FDA announced relaxed wearable device regulations.
Shares of medical device company DexCom (NASDAQ:DXCM) fell 2.6% in the morning session after analysts at Piper Sandler and Bernstein lowered their price targets on the stock, citing concerns over the ...
Hosted on MSN
DexCom's Q4 2025 earnings: What to expect
San Diego, California-based DexCom, Inc. (DXCM) is a medical device company that designs, develops, and commercializes continuous glucose monitoring (CGM) systems. Valued at $27.4 billion by market ...
DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the continuous glucose monitoring (CGM) market. A strong preliminary fourth-quarter ...
If you're looking to hire new employees for your business, you may ask yourself at some point: Should I be running a background check on candidates? Conducting background checks on your potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results